Generic Name:
migalastat
Project Status:
Complete
Therapeutic Area:
Fabry Disease
Manufacturer:
Amicus Therapeutics
Call for patient/clinician input open:
Brand Name:
Galafold
Project Line:
Reimbursement Review
Project Number:
SR0522-000
Call for patient/clinician input closed:
Details
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
Fabry Disease
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: